Global BGM and CGM
Market Report
2024
The global BGM and CGM market size will be USD 22514.5 million in 2024. Rising awareness about plastic pollution and environmental sustainability is expected to boost sales to USD 69618.9346 million by 2031, with a Compound Annual Growth Rate (CAGR) of 17.50% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of BGM and CGM Market Report 2024.
According to Cognitive Market Research, the global BGM and CGM market size will be USD 22514.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 17.50% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global BGM and CGM Market Sales Revenue 2024 | $ 22514.5 Million |
Global BGM and CGM Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.5% |
North America BGM and CGM Sales Revenue 2024 | $ 9005.8 Million |
North America BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 15.7% |
United States BGM and CGM Sales Revenue 2024 | $ 7105.58 Million |
United States BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 15.5% |
Canada BGM and CGM Sales Revenue 2024 | $ 1080.7 Million |
Canada BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.5% |
Mexico BGM and CGM Sales Revenue 2024 | $ 819.53 Million |
Mexico BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.2% |
Europe BGM and CGM Sales Revenue 2024 | $ 6754.35 Million |
Europe BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16% |
United Kingdom BGM and CGM Sales Revenue 2024 | $ 1134.73 Million |
United Kingdom BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.8% |
France BGM and CGM Sales Revenue 2024 | $ 621.4 Million |
France BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 15.2% |
Germany BGM and CGM Sales Revenue 2024 | $ 1337.36 Million |
Germany BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.2% |
Italy BGM and CGM Sales Revenue 2024 | $ 580.87 Million |
Italy BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 15.4% |
Russia BGM and CGM Sales Revenue 2024 | $ 1046.92 Million |
Russia BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 15% |
Spain BGM and CGM Sales Revenue 2024 | $ 553.86 Million |
Spain BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 15.1% |
Rest of Europe BGM and CGM Sales Revenue 2024 | $ 1046.92 Million |
Rest of Europe BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 14.7% |
Asia Pacific BGM and CGM Sales Revenue 2024 | $ 5178.34 Million |
Asia Pacific BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 19.5% |
China BGM and CGM Sales Revenue 2024 | $ 2330.25 Million |
China BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 19% |
Japan BGM and CGM Sales Revenue 2024 | $ 714.61 Million |
Japan BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 18% |
Korea BGM and CGM Sales Revenue 2024 | $ 517.83 Million |
Korea BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 18.6% |
India BGM and CGM Sales Revenue 2024 | $ 621.4 Million |
India BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 21.3% |
Australia BGM and CGM Sales Revenue 2024 | $ 269.27 Million |
Australia BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 19.2% |
Rest of APAC BGM and CGM Sales Revenue 2024 | $ 367.66 Million |
Rest of APAC BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 19.3% |
South America BGM and CGM Sales Revenue 2024 | $ 1125.73 Million |
South America BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.9% |
Brazil BGM and CGM Sales Revenue 2024 | $ 481.81 Million |
Brazil BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.5% |
Argentina BGM and CGM Sales Revenue 2024 | $ 189.12 Million |
Argentina BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.8% |
Colombia BGM and CGM Sales Revenue 2024 | $ 100.19 Million |
Colombia BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.7% |
Peru BGM and CGM Sales Revenue 2024 | $ 92.31 Million |
Peru BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.1% |
Chile BGM and CGM Sales Revenue 2024 | $ 81.05 Million |
Chile BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.2% |
Rest of South America BGM and CGM Sales Revenue 2024 | $ 181.24 Million |
Rest of South America BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16% |
Middle East and Africa BGM and CGM Sales Revenue 2024 | $ 450.29 Million |
Middle East and Africa BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.2% |
Turkey BGM and CGM Sales Revenue 2024 | $ 38.72 Million |
Turkey BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.7% |
Nigeria BGM and CGM Sales Revenue 2024 | $ 47.28 Million |
Nigeria BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.3% |
Egypt BGM and CGM Sales Revenue 2024 | $ 47.28 Million |
Egypt BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 17.5% |
South Africa BGM and CGM Sales Revenue 2024 | $ 71.15 Million |
South Africa BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 18.2% |
GCC Countries BGM and CGM Sales Revenue 2024 | $ 192.72 Million |
GCC Countries BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 18% |
Rest of MEA BGM and CGM Sales Revenue 2024 | $ 53.13 Million |
Rest of MEA BGM and CGM Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 16.2% |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Market Split by Type Outlook: |
|
Market Split by Application Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of BGM and CGM industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
BGM and CGM Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) markets are essential components of diabetes management, offering real-time glucose tracking and long-term health benefits. BGM devices provide periodic glucose readings, while CGM systems continuously monitor glucose levels, alerting users of highs and lows. Driven by the rising prevalence of diabetes, technological advancements, and increasing health awareness, these markets are expanding rapidly. CGM systems, in particular, are seeing growth due to their convenience and improved accuracy. Key players are focusing on innovation to enhance device connectivity, patient comfort, and data integration, further boosting the market's potential.
In March 2023, The U.S. FDA approved Abbott's integration of its FreeStyle Libre 3 and FreeStyle Libre 2 sensors for automated insulin administration (AID) systems with continuous glucose monitoring (iCGM) systems. In the United States, both the FreeStyle Libre 3 and FreeStyle Libre 2 sensors are presently available and approved for usage in people four years of age and up. (Source: https://abbott.mediaroom.com/2023-03-06-U-S-FDA-Clears-Abbotts-FreeStyle-Libre-R-2-and-FreeStyle-Libre-R-3-Sensors-for-Integration-with-Automated-Insulin-Delivery-Systems)
The global rise in diabetes cases significantly drives monitoring and management solutions demand. With diabetes rates on the rise globally, there is a growing need for monitoring devices, especially in regions where lifestyle and dietary changes have led to a surge in type 2 diabetes. Advanced monitoring devices, particularly CGMs, can be expensive, limiting access in low-income populations and countries with insufficient healthcare funding. Overall, the increasing prevalence of diabetes, coupled with technological advancements and rising health awareness, are strong market drivers. However, affordability and access issues continue to restrain more widespread adoption, particularly in underfunded healthcare settings.
Enhancing accuracy and convenience are fueling increased adoption of devices. Improved precision in measurements, diagnostics, and performance strengthens user confidence and reliability, particularly in fields like healthcare, consumer tech, and industrial applications. Streamlined usability and advanced, user-friendly interfaces make devices more accessible, enhancing appeal across diverse demographics. Together, these factors reduce learning curves, speed adoption, and elevate device value, making accurate, convenient technology a preferred choice for both professionals and everyday users.
The key market restraints limiting accessibility for a broader consumer base often include high costs, making products less affordable for a wide range of consumers. Additionally, limited awareness and distribution challenges hinder market reach, especially in rural or underserved areas. Regulatory complexities and strict compliance requirements can also slow down product availability. Lastly, technical limitations in product design or infrastructure can restrict usability, especially for consumers in regions lacking advanced digital resources or connectivity.
The COVID-19 pandemic significantly boosted the Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) markets as healthcare systems emphasized remote patient monitoring. Demand surged due to increased diabetes complications among COVID-19 patients, driving the adoption of CGM devices to minimize hospital visits and enhance glucose management. However, supply chain disruptions briefly affected device availability. Overall, the pandemic accelerated digital health trends, fostering wider acceptance and integration of CGM and BGM technologies into chronic disease management.
We have various report editions of BGM and CGM Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The competitive landscape of the Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) markets is characterized by major players like Dexcom, Abbott, and Medtronic. Innovations in technology, strategic partnerships, and regulatory advancements drive competition, with a focus on improving accuracy, user-friendliness, and data integration in diabetes management.
In February 2023, Ascensia Diabetes Care Holdings AG, the company behind the CONTOUR BGM system portfolio, teamed with SNAQ. This mobile application provides dietary insights for people with diabetes on a global scale. (Source: https://www.prnewswire.com/news-releases/ascensia-diabetes-care-collaborates-with-snaq-to-support-mealtime-decision-making-for-people-with-diabetes-301751098.html) In November 2021, The POGO automatic blood glucose monitoring system was introduced by Intuity Medical for diabetic patients in the United States. The introduction of this device enhances the quality of life for patients. (Source: https://www.mobihealthnews.com/news/intuity-medical-launches-pogo-glucose-monitoring-system)
Top Companies Market Share in BGM and CGM Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the BGM and CGMs market, and the region is expected to have significant growth during the projected period. This is due to advanced healthcare infrastructure, the high prevalence of diabetes, and the strong adoption of innovative monitoring technologies. The region's focus on diabetes management drives significant investment and development in these technologies.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This growth is driven by rising diabetes prevalence, increasing health awareness, and advancements in glucose monitoring technology, fostering greater accessibility and adoption.
The current report Scope analyzes BGM and CGM Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global BGM and CGM market size was estimated at USD 22514.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 9005.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.
According to Cognitive Market Research, the global BGM and CGM market size was estimated at USD 22514.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 6754.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.0% from 2024 to 2031.
According to Cognitive Market Research, the global BGM and CGM market size was estimated at USD 22514.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 5178.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.5% from 2024 to 2031.
According to Cognitive Market Research, the global BGM and CGM market size was estimated at USD 22514.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 1125.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.9% from 2024 to 2031.
According to Cognitive Market Research, the global BGM and CGM market size was estimated at USD 22514.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 450.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031..
Global BGM and CGM Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing BGM and CGM Industry growth. BGM and CGM market has been segmented with the help of its Type Outlook:, Application Outlook: , and others. BGM and CGM market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global BGM and CGM Market?
According to Cognitive Market Research, Continuous Glucose Monitoring (CGM) is rapidly dominating the Blood Glucose Monitoring (BGM) and CGM market due to its ability to provide real-time glucose data, enhancing diabetes management. CGM devices enable users to monitor their glucose levels continuously, reducing the need for frequent fingerstick tests. The convenience and accuracy of CGM technology empower patients to make informed decisions about their diet and insulin use, driving widespread adoption. Moreover, advancements in CGM technology are improving user experience and accessibility, further boosting market growth.
The Blood Glucose Meter (BGM) market is experiencing rapid growth due to advancements in technology, increased diabetes prevalence, and the demand for self-monitoring solutions. Innovative features like Bluetooth connectivity, smartphone integration, and user-friendly designs enhance convenience and data tracking. Additionally, the rise of point-of-care testing and the need for accurate, real-time glucose monitoring in managing diabetes further drive the BGM market's expansion. As awareness of diabetes management increases, BGM adoption continues to dominate the fastest-growing segment alongside Continuous Glucose Monitoring (CGM) systems.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of BGM and CGM Industry. Request a Free Sample PDF!
According to Cognitive Market Research, Households dominate the largest Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) market due to the increasing prevalence of diabetes and health awareness. The growing focus on preventive healthcare drives demand for user-friendly and accurate monitoring devices. Households prioritize convenience, favoring CGM systems that offer real-time data and ease of use. Additionally, technological advancements in mobile health apps and smart devices enhance patient engagement, making BGM and CGM integral for effective diabetes management within households.
In the BGM and CGM markets, Hospitals dominate the fastest-growing Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) market due to the increasing prevalence of diabetes and the need for effective management solutions. Enhanced patient care, technology integration, and the demand for real-time glucose data drive hospital adoption of advanced monitoring systems. Additionally, partnerships with healthcare technology companies facilitate access to cutting-edge devices, further positioning hospitals as leaders in providing comprehensive diabetes care and improving patient outcomes.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type Outlook: | Continuous Glucose Monitoring (CGM), Blood Glucose Meter (BGM) |
Application Outlook: | Household, Hospital |
List of Competitors | Roche, Lifescan, Abbott, Ascensia, ARKRAY, I-SENS, Omron, B. Braun, 77 Elektronika, AgaMatrix, Terumo, Sinocare, Yicheng, Yuwell, Acon, Dexcom, Medtronic, Senseonics Holdings |
This chapter will help you gain GLOBAL Market Analysis of BGM and CGM. Further deep in this chapter, you will be able to review Global BGM and CGM Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Chapter 3 Europe Market Analysis
Chapter 4 Asia Pacific Market Analysis
Chapter 5 South America Market Analysis
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Outlook: Analysis 2019 -2031, will provide market size split by Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Outlook: Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global BGM and CGM market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Continuous Glucose Monitoring (CGM) have a significant impact on BGM and CGM market? |
What are the key factors affecting the Continuous Glucose Monitoring (CGM) and Blood Glucose Meter (BGM) of BGM and CGM Market? |
What is the CAGR/Growth Rate of Household during the forecast period? |
By type, which segment accounted for largest share of the global BGM and CGM Market? |
Which region is expected to dominate the global BGM and CGM Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
BGM and CGM Market
Request Sample